Tip: Index histories & All-time highs

Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 02.02.2022       Cogia AG
GBC AG DE000A3H2226

Preliminary results significantly above forecast, price target confirmed On January 21, 2022, Cogia AG published its preliminary figures for the 2021 financial year and the figures presented exceed the GBC analysts' forecasts. A total output of EUR 1.7 million was achieved in the group, which corresponds to almost a threefold increase (previous  [ … ]
Technical analysis
To the publication
Mon, 31.01.2022       PAION AG
First Berlin Equity Research GmbH DE000A0B65S3

First Berlin Equity Research hat ein Research Update zu PAION AG (ISIN: DE000A0B65S3) veröffentlicht. Analyst Simon Scholes bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 4,10 auf EUR 3,80. Zusammenfassung: Im vergangenen Jahr haben PAIONs Partner Remimazolam in den USA für die Kurzsedierung und in Südkorea f&u [ … ]
Technical analysis
To the publication
Fri, 28.01.2022       HAEMATO AG
GBC AG DE000A289VV1

PCR PoC-Device added to the product portfolio; revenue and earnings forecasts unchanged, upside potential anticipated from new products, price target and BUY rating confirmed In our last management interview (http://www.more-ir.de/d/23165.pdf) on the current developments of HAEMATO AG, the CEO Patrick Brenske had announced the addition of a mobi [ … ]
Technical analysis
To the publication
Thu, 27.01.2022       Valneva SE
First Berlin Equity Research GmbH FR0004056851

First Berlin Equity Research hat ein Research Update zu Valneva SE (ISIN: FR0004056851) veröffentlicht. Analyst Simon Scholes stuft die Aktie auf BUY herauf und bestätigt sein Kursziel von EUR 23,40. Zusammenfassung: Valneva reicht weiterhin Daten zu ihrem COVD-19-Impfstoffkandidaten VLA2001 bei der Europäischen Arzneimittelagentu [ … ]
Technical analysis
To the publication
Tue, 25.01.2022       Ikonisys SA
Sphene Capital GmbH FR00140048X2

Restart of a technology leader in laboratory automation With a share price target of EUR 7.70 and an expected share price performance of 176.0%, we initiate research coverage on the shares of Ikonisys SA with a Buy rating. Our price target is derived from a threestage discounted cash flow entity model (primary valuation method), for which we ca [ … ]
Technical analysis
To the publication
Mon, 24.01.2022       Defence Therapeutics Inc.
GBC AG CA24463V1013

GBC Research Watchlist: Defence Therapeutics Defence Therapeutics is led by Sebastien Plouffe. Mr. Plouffe has been a successful Investment Advisor and CEO notably in the resource sector, leading several junior companies to profitable exits. Mr. Plouffe is supported by Dr. Moutih Rafei, VP R&D and Dr. Simon Beaudoin CTSO. Dr. Rafei is a worl [ … ]
Technical analysis
To the publication
Wed, 19.01.2022       The NAGA Group AG
GBC AG DE000A161NR7

Strong revenue and earnings growth in 2021; guidance for 2022 significantly above our expectations; estimates and share price target raised According to preliminary figures for the past financial year 2021, The NAGA Group AG (short to: NAGA) achieved significant revenue growth as expected. Compared to the previous year, consolidated sales more t [ … ]
Technical analysis
To the publication
Tue, 18.01.2022       Haemato AG
First Berlin Equity Research GmbH DE000A289VV1

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 50,00. Zusammenfassung: Während Omikron Europa stürmt, bemühen sich die Regierungen, die neue Variante zu stoppen, und die st [ … ]
Technical analysis
To the publication
Fri, 14.01.2022       ad pepper media International N.V.
First Berlin Equity Research GmbH NL0000238145

First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 8,10 auf EUR 7,10. Zusammenfassung: ad pepper hat die Q4-Prognose aufgrund der schwächer als erwarteten Ent [ … ]
Technical analysis
To the publication
Thu, 13.01.2022       Knaus Tabbert AG
First Berlin Equity Research GmbH DE000A2YN504

First Berlin Equity Research hat am 13.01.2022 die Coverage von Knaus Tabbert AG (ISIN: DE000A2YN504/ Bloomberg: KTA GR) aufgenommen. Analyst Kimberly Purvis stuft die Aktie mit einem BUY-Rating ein, bei einem Kursziel von EUR 95,00. Zusammenfassung: Knaus Tabbert (KTA) ist ein führendes Unternehmen in der Freizeitfahrzeugbranche. Mit 5 Mar [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 23.06.2025, Calendar Week 26, 174th day of the year, 191 days remaining until EoY.